Abstract:Smoking is the leading cause of preventable cardiovascular disease (CVD). Epidemiologic and biologic evidence consistently demonstrates that smokers have an increased risk of CVD compared to nonsmokers. Both cardiac and extracardiac CVDs are more prevalent among smokers.Secondhand smoke is an important cause of CVD in nonsmokers. Secondhand smoke increases the risk of CVD by at least 30%, and given that a large part of the population is still breathing secondhand smoke, it is vital to counsel patients to avoid secondhand smoke exposure.The effects of tobacco smoke on the cardiovascular system accrue over a short period of time and are synergistic with other established cardiovascular risk factors. Tobacco smoke affects the cardiovascular system within minutes of exposure. Smokers and nonsmokers should be aware of this fact. Smokers should be encouraged to quit, and nonsmokers should fight for smoke-free environments.Every smoker should be encouraged to quit and every patient should be informed about the harmful effects of secondhand smoke (SHS) exposure. Smoking cessation has been proven to decrease mortality, regardless of age at quitting or disease stage. Several pharmacologic agents are now available to help patients quit. Pharmacotherapy is more likely to be effective if complemented with behavioral counseling. Secondhand smoke counseling will increase the likelihood of quitting for a smoker and encourage nonsmokers to advocate for smoke-free environments. At the very least, physicians should refer smokers to a quit line. Options should be discussed with the patient and behavioral treatment should be encouraged as it increases the likelihood of success. Smoking cessation is also effective in reducing CVD mortality. The excess risk of myocardial infarction (MI) is reduced by 50% within 1 year of quitting.Physicians should become tobacco control activists. A comprehensive tobacco control program, that includes taxation, smoke-free environments, and exposing the tobacco industry, has been shown to be effective in decreasing smoking prevalence and cardiovascular disease mortality. Physicians should become actively involved in the fight against tobacco.The mechanisms by which tobacco smoke leads to CVD include platelet activation, endothelial dysfunction, inflammation, altered lipid levels and metabolism, and hemodynamic effects. These effects interact with each other and are synergistic with other established CVD risk factors (e.g., obesity, diabetes). Some of these effects occur soon after exposure has happened; as little as half an hour of SHS exposure leads to platelet and endothelial dysfunction.A comprehensive tobacco control program reduces CVD mortality. Smoke-free environments are among the most effective measures to reduce CVD mortality. In addition to protecting nonsmokers from secondhand smoke, these environments make it easier for smokers to cut down or quit. Physicians should become active tobacco control advocates.

The peripheral vascular consequences of smoking

Smoking and the Pathophysiology of Peripheral Artery Disease

Early Detection of Negative Smoking Impacts: Vascular Adaptation Deviation Based on Quantification of Circulated Endothelial Activation Markers

Pathophysiologic Mechanisms of Tobacco Smoke Producing Atherosclerosis

The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis

Smoking and Atherosclerosis: Mechanisms of Disease and New Therapeutic Approaches

Active and Passive Smoking, Chronic Infections, and the Risk of Carotid Atherosclerosis

Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease.

Combined Effects of Smoking and Peripheral Arterial Disease on All-Cause and Cardiovascular Disease Mortality in a Chinese Male Cohort.

[Impact of Acute Smoking on Artery Function in Healthy Chronic Smokers].

[The role of smoking in changing essential parameters in body homeostasis]

Effects of Smoking on Respiratory System

Long-Term Outcomes in the Smoking Claudicant after Peripheral Vascular Interventions

Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review

Changes in platelet glycoprotein receptors after smoking--a flow cytometric study

Cigarette smoking as a risk factor for atherosclerosis and renal disease: novel pathogenic insights

Smoking as a risk factor for lower extremity peripheral artery disease in women compared to men: A systematic review and meta-analysis

Cigarette smoke impairs pulmonary vascular function through nAChR activation

Smoking, Secondhand Smoke, and Cardiovascular Disease

Chronic cigarette smoke exposure triggers a vicious cycle of leukocyte and endothelial-mediated oxidant stress that results in vascular dysfunction